10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

EPI Insider Trading (ESSA Pharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$604,640.80
Insider Selling (Last 12 Months): C$0.00

ESSA Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at ESSA Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ESSA Pharma Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 12/1/2017 08:15 PM ET

This chart shows the closing price history over time for EPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Your 15 Minute Workday… (Make Extra Cash from Home)
Some people binge watch Netflix… Hulu…or HBO shows. And some people turn their downtime into cash. James made $2,275 in just 19 minutes…all thanks to something called The 15 Minute Workday. The average trade makes 12% in just 5 days (factoring winners and losers) which is out of this world.
Click here to start
pixel

ESSA Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2020Richard GlickmanDirectorBuy5,740C$6.40C$36,736.0039,490
8/21/2020Franklin Milan BergerDirectorBuy24,088C$7.10C$171,024.80858,037
8/19/2020Franklin Milan BergerDirectorBuy50,000C$6.99C$349,280.00814,420
8/17/2020Franklin Milan BergerDirectorBuy7,000C$6.80C$47,600.00664,420
6/15/2020David Sidney WoodSenior OfficerBuy31C$4.85C$150.3516,716
10/31/2019David Sidney WoodSenior OfficerBuy100C$594.00C$59,400.0014,185
10/31/2019Franklin Milan BergerDirectorBuy7,000C$6.08C$42,577.00486,688
10/18/2019Franklin Milan BergerDirectorBuy15,000C$4.85C$72,784.80477,688
See Full Table
Insider Selling at ESSA Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ESSA Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for ESSA Pharma (TSE:EPI)

ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues.
Read More on ESSA Pharma

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

4,700 shs

Average Volume

68,239 shs

Market Capitalization

C$9.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ESSA Pharma?

ESSA Pharma's top insider shareholders include:
  1. Franklin Milan Berger (Director)
  2. Richard Glickman (Director)
  3. David Sidney Wood (Senior Officer)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel